Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Background/Aims Transarterial radioembolization (TARE) has shown promising results in treating advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). However, whether TARE can provide superior or comparable outcomes to tyrosine kinase inhibitor (TKI) in patients with HCC a...

Full description

Bibliographic Details
Main Authors: Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2023-07-01
Series:Clinical and Molecular Hepatology
Subjects:
hepatocellular carcinoma
portal vein tumor thrombus
transarterial radioembolization
sorafenib
lenvatinib
Online Access:http://e-cmh.org/upload/pdf/cmh-2023-0076.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2023-0076.pdf

Similar Items